OAR 836-200-0545
Public Disclosure of Prescription Drug Manufacturer Filings

(1)

As soon as practicable after receiving a filing from a prescription drug manufacturer under OAR 836-200-0530 (Form and Manner Requirements for Drug Pricing Reporting), the department shall post to it’s website the name of the manufacturer and the prescription drug that is the subject of the filing.
(2) No later than the applicable date as specified in subsection (3) following the receipt of a filing from a manufacturer under OAR 836-200-0530 (Form and Manner Requirements for Drug Pricing Reporting) or a response to a request for additional information from a manufacturer under OAR 836-200-0535 (Additional Information Requests), the department shall post to it’s website the information provided by the prescription drug manufacturer in the filing or response.

(3)

Each year, the department shall post the information specified in subsection (2) no later than:
(a) March 31, for filings or responses to requests for additional information received between October 1 and December 31 of the previous calendar year;
(b) June 30, for filings or responses to requests for additional information received between January 1 and March 31;
(c) September 30, for filings or responses to requests for additional information received between April 1 and June 30; and
(d) December 31, for filings or responses to requests for additional information received between July 1 and September 30.

(4)

As soon as practicable after submission of a request for additional information by the department under OAR 836-200-0535 (Additional Information Requests), receipt of a manufacturer’s request for additional time to complete a response under 836-200-0535 (Additional Information Requests), or submission or receipt of any other correspondence pertaining to the filing from the department or the manufacturer, the department shall post these documents to its website.

(5)

Notwithstanding subsections (1) to (4), if a manufacturer has made a trade secret claim, the information that is the subject of the trade secret claim will not be posted to the department’s website until a determination has been made by the department or, in the case of a manufacturer’s appeal, the director, as specified by OAR 836-200-0540 (Information Claimed to be Trade Secret).

(6)

No information determined by the department to be exempt from disclosure under OAR 836-200-0540 (Information Claimed to be Trade Secret) shall be included in the information posted to the department’s website.

Source: Rule 836-200-0545 — Public Disclosure of Prescription Drug Manufacturer Filings, https://secure.­sos.­state.­or.­us/oard/view.­action?ruleNumber=836-200-0545.

836‑200‑0000
Statutory Authority 836‑200‑0010
Assessments 836‑200‑0020
Filing Procedures 836‑200‑0030
Form 10 K and Other Financial Stability Filings 836‑200‑0040
Reimbursement Insurance Policy 836‑200‑0050
Registration Requirements Not Exclusive 836‑200‑0055
Annual Report 836‑200‑0060
Service on Registrant 836‑200‑0100
Notice, Collision Damage Waivers 836‑200‑0105
Statutory Authority 836‑200‑0110
Registration Procedures 836‑200‑0120
Warranty 836‑200‑0130
Reimbursement Insurance Policy 836‑200‑0140
Registration Requirements Not Exclusive 836‑200‑0200
License, Discount Medical Plan Organization 836‑200‑0210
Renewal of expired license 836‑200‑0215
One-time processing fee, cancelled application 836‑200‑0220
License Requirement Not Exclusive 836‑200‑0250
Purpose and Authority 836‑200‑0255
Registration of Contracting Entity 836‑200‑0300
Statement of Purpose 836‑200‑0305
Retainer Medical Practice Application for Certification 836‑200‑0310
Retainer Medical Practice Application for Renewal 836‑200‑0315
Disclosures 836‑200‑0401
Statement of Purpose 836‑200‑0406
Application Requirements for Pharmacy Benefit Manager 836‑200‑0411
Renewal of Pharmacy Benefit Registration 836‑200‑0416
Registration Requirements Not Exclusive 836‑200‑0421
Service on Registrant 836‑200‑0436
Submission of Complaints 836‑200‑0440
Market Conduct Requirements for Pharmacy Benefit Managers 836‑200‑0500
Purpose and Statutory Authority 836‑200‑0505
Definitions 836‑200‑0510
Account Generation Requirement 836‑200‑0515
Threshold for Reporting Drug Price Increase 836‑200‑0520
Threshold for Reporting New Specialty Drug 836‑200‑0525
Expectations of Reporting Manufacturers 836‑200‑0530
Form and Manner Requirements for Drug Pricing Reporting 836‑200‑0535
Additional Information Requests 836‑200‑0540
Information Claimed to be Trade Secret 836‑200‑0545
Public Disclosure of Prescription Drug Manufacturer Filings 836‑200‑0550
Consumer Notices to the Department 836‑200‑0555
Assessments Against Prescription Drug Manufacturers 836‑200‑0560
Civil Penalties
Last Updated

Jun. 8, 2021

Rule 836-200-0545’s source at or​.us